Viewing nowCombinationTeneligliptin Metformin Hydrochloride Extended Release Tablet 10/500 mg
Metformin Hydrochloride 500mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
LightPharm Tech Co., Ltd.

MFDS item code 202202709 · Approved 2022.07.01 · Insurance code 690303590
Improves blood glucose control in patients with type 2 diabetes
This medication is used to assist patients with type 2 diabetes in controlling their blood sugar levels. It is particularly suitable when taken together with Teneligliptin and Metformin, and it is more effective when combined with diet and exercise therapy. This helps manage blood glucose levels more consistently, providing significant assistance in diabetes management.
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000 mg extended-release tablet once daily. Patients taking the 10/750 mg or 10/500 mg extended-release tablets should take two tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from concomitant therapy with teneligliptin and metformin to this medicine, treatment may be started at the doses of teneligliptin and metformin that the patient was previously taking. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted as appropriate. When administered concomitantly with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20 mg and extended-release metformin 2000 mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering agents. Because changes may affect blood glucose control, any change in treatment for patients with type 2 diabetes should be made with careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.
This medication helps control blood sugar levels. However, there are some important precautions to take when using it. First, this medication can rarely cause a serious condition called lactic acidosis. Lactic acidosis can occur if lactic acid accumulates excessively in the body and can be dangerous, so if symptoms such as shortness of breath, muscle pain, abdominal pain, or weakness occur, immediate medical attention should be sought. Additionally, if this medication is taken with insulin or other diabetes medications, there is a risk of hypoglycemia, so if symptoms of hypoglycemia such as dizziness, cold sweats, or trembling occur, sugar should be ingested immediately. Patients with moderate or more renal impairment, heart failure, acute myocardial infarction, or severe infections should not take this medication. In particular, if renal function is low, the drug may accumulate in the body and become dangerous. Furthermore, if tests using radiological contrast agents are to be conducted, this medication should be discontinued 48 hours prior to the test, and after confirming normal kidney function following the test, it can be resumed. Women who are pregnant or may become pregnant should avoid this medication. If nursing, it should also be discussed with a physician whether to continue breastfeeding or halt drug therapy, as the medication may be transmitted through breast milk. This medication is also not administered to patients with impaired liver function. If liver function is compromised, there is an increased risk of side effects due to the accumulation of the drug in the body. Regular blood tests to monitor kidney function and vitamin B12 levels should be done during treatment. This is necessary to prevent anemia or neurological problems due to possible vitamin B12 deficiency. Excessive alcohol consumption should be avoided during this treatment, as alcohol can increase the risk of lactic acidosis. If a major surgery is planned, this medication should be discontinued 48 hours prior to the surgery, and after confirming normal kidney function post-surgery, it can be resumed. This medication carries a risk of hypoglycemia, so caution should be exercised, especially if meals are missed or there is an increase in physical activity. Also, this medication may interact with various other drugs, so if other medications are being taken, it is crucial to inform a physician or pharmacist. Lastly, this medication has not been established for safety and efficacy in children and adolescents, so it should not be used in these populations. It is important to adhere to the precautions outlined above while taking this medication, and any unusual symptoms should prompt immediate consultation with medical personnel.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The recommended storage temperature is room temperature between 1 and 30 degrees Celsius. This will help maintain the drug's efficacy and safety for an extended period.
Orange-colored oval extended-release film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationMetformin Hydrochloride 500mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
LightPharm Tech Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Teneligliptin Ditosylate Dihydrate 37.84mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationMetformin Hydrochloride 750mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Teneligliptin Ditosylate Dihydrate 37.84mg
Tablet · Prescription medication · Combination
Youngjin Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
Youngjin Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 750mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
Youngjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.